Arizona Tribune - News from Phoenix, Arizona, the United States and around the world

Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United States

Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today that the European Patent Office intends to grant the Company a patent covering biodegradable polymeric nanoparticles created for carrying therapeutic and targeting agents. With particular utility in cancer therapies, this innovative platform is designed to enhance the delivery of therapeutic antibodies and peptides, which are often limited by enzymatic degradation and poor systemic circulation.

~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~

Urgent.ly, Inc. (Nasdaq:ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today announced that management will present virtually in the Investor Summit Microcap Forum on Thursday, November 21, 2024. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Q3 2024 Results and Subsequent Events - Highlights and Headlines:

NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Court awards full attorney fees after Mann Construction, an RPT, LLC client, prevails in dispute over IRS penalty related to Restricted Property Trust transactions.

- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial -- Dermata continues discussions with potential botulinum toxin partners for DMT410 -- Raised $5.1 million in gross proceeds from financings completed in 3Q 2024 -

Build Show LIVE, the brand-new tradeshow held last week in the heart of Austin, was the launch of a transformative movement, bringing together passionate builders, remodelers, architects and manufacturers from 47 states and nine countries, who are committed to elevating the future of residential construction.

Flutter Entertainment announces launch of first tranche of share repurchase program

Based on real-world experience of 22 organizations, the study provides insights and tools for engaging stakeholders and securing funding.

DehydraTECH clinical test article manufacturing has been completed

Gryphon Digital Mining, Inc. (Nasdaq:GRYP) ("Gryphon," the "Company," "we," "our," and "us"), a bitcoin mining company that is focused on becoming the leader in low-cost, efficient operations, today reported financial results for its quarter ended September 30, 2024.

Users Can Now Access More Zedge Content and Get Increased Value from Zedge Credit Purchases Made on the WebsiteModernized user interface mirrors mobile app

ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three and nine months ended September 30, 2024.

2024 Third Quarter Financial Highlights:Net income was $959,000 compared to $776,000 for the second quarter of 2024.Deposits increased $32.7 million, or 6.1%, from the second quarter of 2024. Annualized growth of 9.3%.Loans receivable increased $1.5 million, or 0.3%, from the second quarter of 2024. Annualized growth of 7.0%.Nonperforming assets to total assets decreased to 0.00% compared to 0.08% for the second quarter of 2024.Tangible book value per share increased to $13.45 compared to $12.52 for the second quarter of 2024.Capital ratios remained well above regulatory requirements.

Strategic Filing Aims to Protect Operational Continuity for the Benefit of Stockholders

Australians continue to prioritise travel and Liberty has personal loan solutions to help move their holiday plans forward.

(NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will participate in the Craig-Hallum 15th Annual Alpha Select Conference taking place on November 19, 2024 at the Sheraton New York Times Square Hotel. President and CEO Gayn Erickson and CFO Chris Siu will be hosting meetings with institutional investors throughout the day.

Pure Cycle Corporation (NASDAQ Capital Market:PCYO) announced its financial results for the year ended August 31, 2024. Pure Cycle reported $11.6 million of net income for the year ended August 31, 2024, which is a 147% increase compared to 2023, and marks our seventh consecutive year and twenty-first consecutive fiscal quarter with positive net income. Pure Cycle reported $0.48 of earnings per fully diluted common shares, which is up from $0.19 in 2023, a 153% increase. We recognized a 135% increase in lot sales revenue for the year ended August 31, 2024 compared to 2023, due to an increase in our development activity. Pure Cycle continues to develop its Sky Ranch Master Planned Community, and as of August 31, 2024, we are actively working on Phases 2A, 2B and 2C. Phase 2A and 2B are substantially completed with finished lots delivered to homebuilders. We expect home builders to be able to begin construction in Phase 2C during fiscal 2025 and to start home building in Phase 2D in fiscal 2026.

Insights Reveal the Need for News Organizations to Transform Operations to Thrive in a Rapidly Changing Landscape

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation of CTCs

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 million and 11% versus net Q3 2023 revenue of $2.8 millionJaguar reported significant results in breast cancer patients in its phase 3 OnTarget trial for its cancer supportive care drug crofelemer; results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS)Jaguar initiated commercial launch in October 2024 for Gelclair®, the company's third prescription product, in alignment with Jaguar's focus on cancer supportive careJaguar is initiating two Phase 2 trials in Q4, 2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel syndrome (SBS) with intestinal failure in the US, EU, and Middle East/North Africa (MENA) regions; results of IITs expected by the end of 2024 and throughout 2025REMINDER: Jaguar to host investor webcast Wednesday, November 13th at 8:30 a.m. Eastern regarding Q3 2024 financials and company updates; Click here to register for webcast

SRH Total Return Fund, Inc. (NYSE:STEW) (the "Fund") is pleased to announce a 20% increase in the Fund's quarterly distribution to $0.165 per share beginning in January 2025, payable on the date noted below. This is the fourth consecutive annual increase of the Fund's managed distribution. The distribution has been increased by 12.8% annually over the last four years. This distribution is being paid as part of the Fund's managed distribution program, under which the Fund intends to make per share distributions of $0.165 per quarter, or approximately $0.66 per year, to common stockholders. As of market close on November 8, 2024, the distribution (on an annualized basis) amounts to approximately 4.07% of the Fund's market price and 3.13% of its net asset value ("NAV"). The January 2025 quarterly distribution will be payable in cash to stockholders of record per the following critical dates:

Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced earnings for its fourth quarter and fiscal year ended September 30, 2024. Please read the Company's Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov and the Investors section of the Company's website at www.GladstoneCapital.com.

Mawson Gold Limited ("Mawson" or the "Company") (TSXV:MAW)(Frankfurt:MXR)(PINKSHEETS:MWSNF) announces Southern Cross Gold Ltd. ("Southern Cross Gold" or "SXG") has released results from five navigational diamond drill holes (SDDSC050W1, 050W2, 092W1, 092W2 and 092W3) at the Rising Sun prospect, at the 100%-owned Sunday Creek Gold-Antimony Project in Victoria (Figure 5).

Loar Holdings Inc. (NYSE:LOAR) (the "Company," "Loar," "we," "us" and "our"), reported record results for the third quarter of 2024.

Survey shows overwhelming interest in AI tools, but lack of in-house technical expertise creates barriers to implementation.

A strategic move to further expand global delivery capabilities across the SAP ecosystem

Bucher + Suter, a leader in contact center solutions, has announced a partnership with Upstream Works, a provider of omnichannel and AI contact center solutions. This collaboration enhances Bucher + Suter's private cloud offerings by integrating Upstream Works' advanced omnichannel capabilities, providing customers with expanded engagement options beyond the current Cisco ECE platform.

Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub ("CPP"), today announced financial data for the third quarter 2024 and other company highlights.

Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced that it will report 2024 3rd quarter financial data on Wednesday, November 13th after the markets close. Noble Roman's also announced that it will host a conference call on Thursday, November 14th from 4:00 to 4:45 PM EST. Those interested in participating in the conference call should dial in at 317-300-7896 and use the participation code 499795 (no pin number required - callers will press 5* to ask questions when Q&A time is announced).